Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News ADMA Biologics Inc ADMA

Healthcare Biotechnology
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product... see more

Current News (NDAQ:ADMA)

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

GlobeNewswire 6 days ago

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

GlobeNewswire 13 days ago

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 5, 2025

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

GlobeNewswire October 29, 2025

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire August 6, 2025

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

GlobeNewswire July 30, 2025

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire May 7, 2025

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

GlobeNewswire April 30, 2025

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

GlobeNewswire April 28, 2025
View More News ››

Opinion & Analysis (NDAQ:ADMA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ADMA)

RE:Did anyone BTFD today?

Here it comes....down again...let's break to a N.L.O.D...what do u say ?
Iseneschal - April 29, 2021

Did anyone BTFD today?

Sub $2....... yeppers !!! Will add if get down there again. Cheers !
Iseneschal - April 29, 2021

Cheaper is better

Let's do it
Iseneschal - April 29, 2021

RE:Always remember......

Ceash ...boom ....bang....... Great !!!!  Sub-$2........let's do it ....... Here comes Joe the Bear
Iseneschal - April 29, 2021

Always remember......

Cream always rises to the top ! I was hoping that this would go lower to add to my position..... that hasn't happened so I'm...
Iseneschal - April 29, 2021

RE:Meh.......This will bleed out

Oh well .... I'm up a few bucks......My bad ! Cheers !
Iseneschal - April 29, 2021
View more Bullboard ››

AJN Resources Inc.

AJN Resources Inc.

AJN Resources Inc. is a Canada-based junior exploration company and is engaged in the exploration and evaluation of mineral ...
View More »

Podcasts